Search research articles
Contact Us
Filters
Showing results (751-760 of 781) with videos related to
Page
of 79
Sort By:
American Journal of Hematology
|
October 18, 2018
A phase II study of omacetaxine mepesuccinate for patients with higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia after failure of hypomethylating agents
Nicholas J Short, Elias Jabbour, Kiran Naqvi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 22, 2026
Investigational clinical trial agents versus conventional second salvage therapies in patients with relapsed/refractory acute myeloid leukemia
Daniel Nguyen, Hagop M Kantarjian, Aram Bidikian, et al.
Zhonghua Shao Shang Za Zhi = Zhonghua Shaoshang Zazhi = Chinese Journal of Burns
|
August 30, 2013
[Multi-center clinical trial of FLAMIGEL (hydrogel dressing) for the treatment of residual burn wound]
Hui-zhong Yang, Wen-kui Wang, Li-li Yuan, et al.
Cancer
|
August 3, 2021
Ten-day decitabine with venetoclax versus intensive chemotherapy in relapsed or refractory acute myeloid leukemia: A propensity score-matched analysis
Abhishek Maiti, Courtney D DiNardo, Wei Qiao, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
November 25, 2021
Artificial intelligence modelling in differentiating core biopsies of fibroadenoma from phyllodes tumor
Chee Leong Cheng, Nur Diyana Md Nasir, Gary Jian Zhe Ng, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 13, 2020
Coblopasvir and sofosbuvir for treatment of chronic hepatitis C virus infection in China: A single-arm, open-label, phase 3 trial
Yanhang Gao, Fei Kong, Guangming Li, et al.
Leukemia & Lymphoma
|
April 20, 2022
A multi-arm phase Ib/II study designed for rapid, parallel evaluation of novel immunotherapy combinations in relapsed/refractory acute myeloid leukemia
Nicholas J Short, Gautam Borthakur, Naveen Pemmaraju, et al.
Leukemia
|
June 18, 2020
Phase II trial of CPX-351 in patients with acute myeloid leukemia at high risk for induction mortality
Ghayas C Issa, Hagop M Kantarjian, Lianchun Xiao, et al.
The Lancet. Diabetes & Endocrinology
|
June 24, 2025
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Linong Ji, Leili Gao, Haibo Xue, et al.
Journal of Hematology & Oncology
|
November 28, 2025
A phase 1/2 study of DS-1594 menin inhibitor in relapsed/refractory acute leukemias
Jayastu Senapati, Marina Konopleva, Ghayas C Issa, et al.
Page
of 79
Search research articles
Search
Showing results (751-760 of 781) with videos related to
Sort By:
Page
of 79
American Journal of Hematology
|
October 18, 2018
A phase II study of omacetaxine mepesuccinate for patients with higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia after failure of hypomethylating agents
Nicholas J Short, Elias Jabbour, Kiran Naqvi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 22, 2026
Investigational clinical trial agents versus conventional second salvage therapies in patients with relapsed/refractory acute myeloid leukemia
Daniel Nguyen, Hagop M Kantarjian, Aram Bidikian, et al.
Zhonghua Shao Shang Za Zhi = Zhonghua Shaoshang Zazhi = Chinese Journal of Burns
|
August 30, 2013
[Multi-center clinical trial of FLAMIGEL (hydrogel dressing) for the treatment of residual burn wound]
Hui-zhong Yang, Wen-kui Wang, Li-li Yuan, et al.
Cancer
|
August 3, 2021
Ten-day decitabine with venetoclax versus intensive chemotherapy in relapsed or refractory acute myeloid leukemia: A propensity score-matched analysis
Abhishek Maiti, Courtney D DiNardo, Wei Qiao, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology
|
November 25, 2021
Artificial intelligence modelling in differentiating core biopsies of fibroadenoma from phyllodes tumor
Chee Leong Cheng, Nur Diyana Md Nasir, Gary Jian Zhe Ng, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
October 13, 2020
Coblopasvir and sofosbuvir for treatment of chronic hepatitis C virus infection in China: A single-arm, open-label, phase 3 trial
Yanhang Gao, Fei Kong, Guangming Li, et al.
Leukemia & Lymphoma
|
April 20, 2022
A multi-arm phase Ib/II study designed for rapid, parallel evaluation of novel immunotherapy combinations in relapsed/refractory acute myeloid leukemia
Nicholas J Short, Gautam Borthakur, Naveen Pemmaraju, et al.
Leukemia
|
June 18, 2020
Phase II trial of CPX-351 in patients with acute myeloid leukemia at high risk for induction mortality
Ghayas C Issa, Hagop M Kantarjian, Lianchun Xiao, et al.
The Lancet. Diabetes & Endocrinology
|
June 24, 2025
Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Linong Ji, Leili Gao, Haibo Xue, et al.
Journal of Hematology & Oncology
|
November 28, 2025
A phase 1/2 study of DS-1594 menin inhibitor in relapsed/refractory acute leukemias
Jayastu Senapati, Marina Konopleva, Ghayas C Issa, et al.
Page
of 79